Features of the course of influenza in some categories of neurological patients
https://doi.org/10.51793/OS.2021.24.3.011
Abstract
The article discusses issues related to the peculiarities of the course of influenza against the background of neurological diseases: influenza in epilepsy and other conditions characterized by increased convulsive readiness, influenza in some pathologies of the peripheral nervous system, influenza in neuromuscular diseases and multiple sclerosis, influenza and cerebral vascular pathology. In a number of patients with diseases of the nervous system, contact with influenza virus and infectious process are accompanied by an increased risk of the disease exacerbation, worsening the prognosis, need for hospitalization, and poor outcomes. The expediency and priority of influenza vaccine prophylaxis in persons with specific nosologies that are within the competence of a neurologist are discussed. In many cases, in neurological patients, vaccination is recognized as an effective measure to prevent the severe course of influenza and complicationы emergence. Doctors need in-depth knowledge of the indications and limitations of influenza vaccination in patients with nervous system disorders.
About the Authors
E. G. Demianovskaya
State Budgetary Healthcare Institution «Infectious Clinical Hospital No. 1 of the Moscow City Health Department»; Federal state budgetary institution of additional professional education «Central State Medical Academy» Administration of the President of the Russian Federation
Россия
Россия
Moscow
A. S. Vasiliev
Federal state budgetary institution of additional professional education «Central State Medical Academy» Administration of the President of the Russian Federation
Россия
Россия
Moscow
References
1. Radzišauskienė D., Vitkauskaitė M., Žvinytė K., Mameniškienė R. Neurological complications of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A // Brain Behav. 2021; 11 (1): e01916. DOI: 10.1002/brb3.1916.
2. Vlajinac H., Dzoljic E., Maksimovic J., Marinkovic J., Sipetic S., Kostic V. Infections as a risk factor for Parkinson's disease: A case-control study // International Journal of Neuroscience, 2013; 123: 329-332. 10.3109/00207454.2012.760560.
3. Taubenberger J. K. The origin and virulence of the 1918 «Spanish» influenza virus // Proc Am Philos Soc. 2006; 150: 86-112.
4. Park C. H., Ishinaka M., Takada A., Kida H., Kimura T., Ochiai K., et al. The invasion routes of neurovirulent A Hong Kong 483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice // Arch. Virol. 2002; 147: 1425- 1436. 10.1007/s00705-001-0750-x.
5. Bohmwald K., Gálvez N. M. S., Ríos M., Kalergis A. M. Neurologic Alterations Due to Respiratory Virus Infections // Front Cell Neurosci. 2018; 12: 386. Published 2018 Oct 26. DOI: 10.3389/fncel.2018.00386.
6. Hosseini S., Wilk E., Michaelsen-Preusse K., Gerhauser I., Baumgärtner W., Geffers R., et al. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function // J. Neurosci. 2018; 38: 3060-3080. 10.1523/JNEUROSCI.1740-17.2018.
7. Toovey S. Influenza-associated central nervous system dysfunction: A literature review // Travel Med Infect Dis. 2008; 6: 114-124.
8. Hauge S. H., Bakken I. J., de Blasio B. F., Håberg S. E. Risk conditions in children hospitalized with influenza in Norway, 2017-2019 // BMC Infect Dis. 2020; 20 (1): 769. Published 2020 Oct 19. DOI: 10.1186/s12879-020-05486-6.
9. Keren R., Zaoutis T. E., Bridges C. B., Herrera G., Watson B. M., Wheeler A. B., et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection // Jama. 2005; 294 (17): 2188-2194. DOI: 10.1001/jama.294.17.2188.
10. Wieching A., Benser J., Kohlhauser-Vollmuth C., Weissbrich B., Streng A., Liese J. G. Clinical characteristics of pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Northern Bavaria, Germany // BMC Res Notes. 2012; 5: 304. Published 2012 Jun 18. DOI: 10.1186/1756-0500-5-304.
11. Marpole R., Blackmore A. M., Gibson N., Cooper M. S., Langdon K., Wilson A. C.. Evaluation and Management of Respiratory Illness in Children With Cerebral Palsy // Front Pediatr. 2020; 8: 333. Published 2020 Jun 24. DOI: 10.3389/fped.2020.00333.
12. Weng T. C., Chiu H. R., Chen S. Y., Shih F. Y., King C. C., Fang C. C. National retrospective cohort study to identify age-specific fatality risks of comorbidities among hospitalised patients with influenza-like illness in Taiwan // BMJ Open. 2019; 9 (6): e025276. Published 2019 Jun 24. DOI: 10.1136/bmjopen-2018-025276.
13. Hayase Y., Tobita K. Influenza virus and neurological diseases // Psychiatry Clin Neurosci. 1997; 51 (4): 181-184. DOI: 10.1111/j.1440-1819.1997.tb02580.x. PMID: 9316161.
14. Yamana M., Kuwahara M., Fukumoto Y., Yoshikawa K., Takada K., Kusunoki S. Guillain-Barré syndrome and related diseases after influenza virus infection // Neurol Neuroimmunol Neuroinflamm. 2019; 21: e575.
15. Hughes R. A., Hadden R. D., Gregson N. A., Smith K. J. Pathogenesis of GuillainBarré syndrome // J Neuroimmunol. 1999; 100: 74-97.
16. Hara M., Morita A., Ichihara K., et al. Miller Fisher syndrome associated with influenza A infection // Intern Med. 2012; 51: 2621-2623.
17. Peleg A. Y., Weerarathna T., McCarthy J. S., Davis T. M. Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control // Diabetes Metab Res Rev. 2007; 23: 3-13.
18. Miller A. C., Subranian R. A., Safi F., Sinert R., Zehtabchi S., Elamin E. M. Influenza A 2009 (H1N1) virus in admitted and critically ill patients // J Intensive Care Med. 2011; 27: 25-31.
19. Luís Ribeiro, Ana Monteiro, João Martins. Hyperacute relapse of Lewis-Sumner syndrome during influenza A (H1N1) virus infection // BMC Neurol. 2020; 20: 427. Published online 2020 Nov 24. DOI: 10.1186/s12883-020-02008-4.
20. Gibson S. B., Majersik J. J., Smith A. G., Bromberg M. B. Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic // Journal of neurosciences in rural practice. 2013; 4: 51-54.
21. Servidei S., Miranda A. F., Gamboa E. T. Infectivity of influenza B virus in cultured human muscle // Acta Neuropathol. 1987; 73: 67-76.
22. Bartley J. M., Pan S. J., Keilich S. R., et al. Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy // Aging (Albany NY). 2016; 8 (4): 620-635. DOI: 10.18632/aging.100882.
23. Borgatta B., Perez M., Rello J., Vidaur L., Lorente L., Socias L., Pozo J. C., Pozo J., Garnacho-Montero J., Rello J. Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection // Intensive Care Med. 2012; 38: 1152-1161.
24. Li T., Qi N., Gao X., Yu H. Rescue of four pediatric patients with severe influenza A (H3N2) in Weifang, China // J Int Med Res. 2018; 46 (11): 4800-4805. DOI: 10.1177/0300060518792795.
25. Kalita J., Kohat A. K., Misra U. K. Predictors of outcome of myasthenic crisis // Neurol Sci. 2014; 35: 1109-1114.
26. Sussman J., Farrugia M. E., Maddison P., et al. Myasthenia gravis: Association of British Neurologists’ management guidelines // Practical Neurology. 2015; 15: 199-206.
27. Buljevac D., Flach H. Z., Hop W. C., et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations // Brain. 2002; 125 (Pt 5): 952-960. DOI: 10.1093/brain/awf098.
28. Williamson E. M., Berger J. R. Infection risk in patients on multiple sclerosis therapeutics // CNS Drugs. 2015; 29 (3): 229-244. DOI: 10.1007/s40263-015-0226-2.
29. Marrie R. A., Elliott L., Marriott J., et al. Dramatically changing rates and reasons for hospitalization in multiple sclerosis // Neurology. 2014; 83 (10): 929-937. DOI: 10.1212/WNL.0000000000000753.
30. Mailand M. T., Frederiksen J. L. Vaccines and multiple sclerosis: a systematic review // J Neurol. 2016. DOI: 10.1007/s00415-016-8263-4.
31. Ghaderi S., Berg-Hansen P., Bakken I. J., Magnus P., Trogstad L., Håberg S. E. Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway // Eur J Epidemiol. 2020; 35 (4): 355-362. DOI: 10.1007/s10654-019-00595-2.
32. Panginikkod S., Rayi A., Rocha Cabrero F., Rukmangadachar LA. Uhthoff Phenomenon. 2020 Oct 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 29261916.
33. Grau A. J., Fischer B., Barth C., Ling P., Lichy C., Buggle F. Influenza vaccination is associated with a reduced risk of stroke // Stroke. 2005; 36 (7): 1501-1506.
34. Grohskopf L. A., Sokolow L. Z., Broder K. R., Olsen S. J., Karron R. A., Jernigan D. B., et al. Prevention and control of seasonal influenza with vaccines // MMWR Recomm Rep. 2016; 65: 1-54.
35. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014 // MMWR Recomm Rep. 2013; 62: 1-43.
36. Phrommintikul A., Kuanprasert S., Wongcharoen W., Kanjanavanit R., Chaiwarith R., Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome // Eur Heart J. 2011; 32 (14): 1730-1735.
37. American Diabetes Association (ADA) Standards of medical care in diabetes-2011 // Diabetes Care. 2011; 33: S11-61.
38. Centers for Disease Control and Prevention (CDC) The Pink Book: Chapters Epidemiology and Prevention of Vaccine Preventable Diseases. 12th Edition. 2011.
39. Chiu S. S., Tse C. Y., Lau Y. L., Peiris M. Influenza a infection is an important cause of febrile seizures // Pediatrics. 2001; 108 (4): E63. DOI: 10.1542/peds.108.4.e63.
40. Greenwood V. J., Crawford N. W., Walstab J. E., Reddihough D. S. Immunisation coverage in children with cerebral palsy compared with the general population // J Paediatr Child Health. 2013; 49: 137-41. 10.1111/jpc.12097.
41. Smith M., Peacock G., Uyeki T. M., Moore C. Influenza vaccination in children with neurologic or neurodevelopmental disorders // Vaccine. 2015; 33 (20): 2322- 2327. DOI: 10.1016/j.vaccine.2015.03.050.
42. McNicholas N., Chataway J. Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination // J Neurol. 2011; 258 (8): 1545-1547.
43. Auriel E., Gadoth A., Regev K., Karni A. Seasonal and H1N1v influenza vaccines in MS: safety and compliance // J Neurol Sci. 2012; 314 (1-2): 102-103.
44. Mailand M. T., Frederiksen J. L. Vaccines and multiple sclerosis: a systematic review // J Neurol. 2016. DOI: 10.1007/s00415-016-8263-4.
45. Baghbanian S. M. Influenza vaccination in patients with multiple sclerosis is possible with some considerations // Iran J Neurol. 2016; 15 (2): 109-110.
46. Schwid S. R., Decker M. D., Lopez-Bresnahan M. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a // Neurology. 2005; 65 (12): 1964-1966.
47. Vagberg M., Kumlin U., Svenningsson A. Humoral immune response to influenza vaccine in natalizumab-treated MS patients // Neurol Res. 2012; 34 (7): 730-733.
48. Bar-Or A., Freedman M. S., Kremenchutzky M., Menguy-Vacheron F., Bauer D., Jodl S., et al. Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis // Neurology. 2013; 81 (6): 552-558.
49. Van Assen S., Holvast A., Benne C. A., Posthumus M. D., van Leeuwen M. A., Voskuyl A. E., et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab // Arthritis Rheum. 2010; 62 (1): 75-81.
50. Olberg H. K., Cox R. J., Nostbakken J. K., Aarseth J. H., Vedeler C. A., Myhr K. M. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study // Mult Scler. 2014; 20 (8): 1074-1080.
51. Kappos L., Mehling M., Arroyo R., Izquierdo G., Selmaj K., Curovic-Perisic V., et al. Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis // Neurology. 2015; 84 (9): 872-879.
52. Abu-Shakra M., Press J., Varsano N., Levy V., Mendelson E., Sukenik S., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus // J Rheumatol. 2002; 29 (12): 2555-2557.
53. Hackman P., Savarese M., Carmignac V., et al. Salih Myopathy. 2012 Jan 12 [Updated 2019 Apr 11]. In: Adam M. P., Ardinger H. H., Pagon R. A., et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
54. Электронный ресурс https://wfneurology.org/2019-08-18-aan-neurologytoday Дата обращения 08.02.2021 г. [Elektronnyy resurs [Electronic resource] https://wfneurology.org/2019-08-18-aan-neurology-today Data obrashcheniya 08.02.2021.]
Review
For citations:
Demianovskaya E.G., Vasiliev A.S. Features of the course of influenza in some categories of neurological patients. Lechaschi Vrach. 2021;(3):56-61. (In Russ.) https://doi.org/10.51793/OS.2021.24.3.011
Views:
712
JATS XML
Email this article 
